Related Experiment Videos
Herpes simplex virus reactivation in surgical patients
Critical Care Medicine
|August 1, 1984
Summary
Critically ill surgical patients shedding herpes simplex virus (HSV) orally showed no outcome correlation. However, a lack of antibody response during shedding indicated high mortality, suggesting impaired immunity.
Area of Science:
- Immunology
- Virology
- Critical Care Medicine
Background:
- Herpes simplex virus (HSV) reactivation can indicate compromised host defense.
- Critically ill patients often experience impaired immune function.
Purpose of the Study:
- To investigate oral HSV shedding in critically ill surgical patients.
- To assess HSV reactivation as a marker of host defense in this population.
- To correlate HSV shedding and immune response with patient outcomes.
Main Methods:
- Studied 44 critically ill surgical patients for oral HSV shedding.
- Compared shedding rates with 50 healthy controls and 42 elective surgery patients.
- Monitored for specific HSV antibody response and correlated with mortality.
Main Results:
- 18 (41%) critically ill patients exhibited persistent oral HSV shedding.
- No controls shed HSV; 10% of elective surgery patients had transient shedding.
- Oral HSV shedding did not correlate with outcome in critically ill patients.
- Failure to mount an HSV antibody rise during shedding was linked to high mortality.
Conclusions:
- Critically ill surgical patients frequently show endogenous HSV reactivation.
- Impaired cell-mediated and humoral immunity are evident in this patient group.
- HSV antibody response, not shedding alone, may predict mortality in critically ill patients.